Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer.
Rubin
J
J
Charboneau
J W
JW
Reading
C
C
Kovach
J S
JS
D000328:Adult; D000917:Antibody Formation; D002277:Carcinoma / Q000556:secondary* / Q000628:therapy*; D002985:Clinical Protocols; D015179:Colorectal Neoplasms; D004274:DNA, Recombinant / Q000008:administration & dosage*; D005260:Female; D018014:Gene Transfer Techniques; D015793:HLA-B7 Antigen / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D007258:Informed Consent; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy*; D008297:Male; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000276:immunology
D004274:DNA, Recombinant; D015793:HLA-B7 Antigen; D011993:Recombinant Fusion Proteins